Ascend Wellness Holdings (AAWH) Non Operating Income (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Non Operating Income came in at -$20.1 million in Q1 2026, down 87.92% year-on-year from -$166.7 million in Q1 2025, and down 31.62% quarter-over-quarter from -$15.3 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Non Operating Income (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Non Operating Income history runs 7 years deep, the most recent figure standing at -$20.1 million for Q1 2026.
- On a quarterly basis, Non Operating Income fell 87.92% year-over-year to -$20.1 million in Q1 2026; TTM through Mar 2026 was -$59.2 million, a 25.89% decrease from a year earlier, with the FY2025 full-year figure at -$49.8 million, down 11.78% from the prior year.
- Non Operating Income fell to -$20.1 million in Q1 2026 per AAWH's latest filing, from -$15.3 million in the prior quarter.
- Across five years, Non Operating Income topped out at $13.6 million in Q2 2023 and bottomed at -$20.1 million in Q1 2026.
- The 5-year median for Non Operating Income is -$8.7 million (2023), against an average of -$9.3 million.
- Across the five-year window, Non Operating Income jumped 249.13% in 2023 and plunged 160.13% in 2024, its largest moves.
- Year by year, Non Operating Income stood at -$8.5 million in 2022, then increased by 6.63% to -$7.9 million in 2023, then tumbled by 52.53% to -$12.1 million in 2024, then retreated by 26.4% to -$15.3 million in 2025, then slumped by 31.62% to -$20.1 million in 2026.
- Per Business Quant, the three latest AAWH Non Operating Income figures stand at -$20.1 million (Q1 2026), -$15.3 million (Q4 2025), and -$12.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -216.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 20.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -7.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 53.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Ascend Wellness Holdings | 83.00 Mn | 22.91 Mn | 44.88 Mn | -20.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.13 Mn |
| Dec 31, 2025 | -15.30 Mn |
| Sep 30, 2025 | -12.22 Mn |
| Jun 30, 2025 | -11.57 Mn |
| Mar 31, 2025 | -10.71 Mn |
| Dec 31, 2024 | -12.10 Mn |
| Sep 30, 2024 | -16.07 Mn |
| Jun 30, 2024 | -8.16 Mn |
| Mar 31, 2024 | -8.23 Mn |
| Dec 31, 2023 | -7.93 Mn |
| Sep 30, 2023 | -8.06 Mn |
| Jun 30, 2023 | 13.56 Mn |
| Mar 31, 2023 | -8.71 Mn |
| Dec 31, 2022 | -8.50 Mn |
| Sep 30, 2022 | -8.16 Mn |
| Jun 30, 2022 | -9.10 Mn |
| Mar 31, 2022 | -5.93 Mn |
| Dec 31, 2021 | -7.34 Mn |
| Sep 30, 2021 | -12.33 Mn |
| Jun 30, 2021 | -36.81 Mn |